Home NDC 58406-435 ENBREL
Product NDC 58406-435
11-digit product format 584060435
Labeler code 58406
Product ID 58406-435_e4897db8-5f5d-4216-b8ac-dbada29e8709
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name etanercept
Dosage form SOLUTION
Route SUBCUTANEOUS
Labeler Immunex Corporation
Application BLA103795
Marketing category BLA
Marketing start 2005-10-06
Marketing end 0000-00-00
Substance ETANERCEPT
Active strength 50 mg/mL
Pharmacologic classes Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ENBREL ETANERCEPT Immunex Corporation a002b40c-097d-47a5-957f-7a7b1807af7f 2026-05-11 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA103795
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 103795 Enbrel etanercept 351(a) Disc 2026-06-01
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 58406-435-04 58406043504 4 SYRINGE in 1 CARTON (58406-435-04) > 1 mL in 1 SYRINGE (58406-435-01) 4 syringe 2005-10-06 0000-00-00 No No Current